4-1BB Antibody Enhances Cytotoxic Activity of Natural Killer Cells Against Prostate Cancer Cells Via NKG2D Agonist Combined with IL-27
Authors:
- 19 July 2022
- journal article
- research article
- Published by Taylor & Francis in Immunotherapy
- Vol. 14 (13) , 1043-1053
Abstract
Aims: To enhance the cytotoxicity of natural killer (NK) cells against prostate cancer cells via NKG2D agonist, with 4-1BB antibody and IL-27 combination. Materials & methods: FACS was used to dete...Keywords
Funding Information
- Project of Chongqing Science and Technology Commission (cstc2020jcyj-msxmX0085)
This publication has 46 references indexed in Scilit:
- Role of inositol phospholipid signaling in natural killer cell biologyFrontiers in Immunology, 2013
- CD137 stimulation enhances the antilymphoma activity of anti-CD20 antibodiesBlood, 2011
- Peripheral 4-1BB Signaling Negatively Regulates NK Cell Development through IFN-γThe Journal of Immunology, 2010
- Anti-tumor immune response induced by dendritic cells transduced with truncated PSMA IRES 4-1BBL recombinant adenovirusesCancer Letters, 2010
- CD137 ligand mediates opposite effects in human and mouse NK cells and impairs NK-cell reactivity against human acute myeloid leukemia cellsBlood, 2010
- NKG2D ligands in tumor immunityOncogene, 2008
- 4-1BB regulates NKG2D costimulation in human cord blood CD8+ T cellsBlood, 2008
- Activation, coactivation, and costimulation of resting human natural killer cellsImmunological Reviews, 2006
- The DNA damage pathway regulates innate immune system ligands of the NKG2D receptorNature, 2005
- Potent Antitumor Activity of Interleukin-27Cancer Research, 2004